thought leadership
World EPA Congress: navigating the changes to EU HTA
February 15, 2024
Access, pricing, and reimbursement requirements and dynamics in Europe are rapidly evolving. Added layers of strategic complexity and time restrictions mean that biopharmaceutical manufactures need a new approach.
Meet the experts from Avalere Health at World EPA Congress on March 12 and 13, 2024, in Amsterdam. We are there to help you re-evaluate strategy, shift beliefs, and increase collaboration to achieve and maintain quality access.
Book your meeting today
Meet with Avalere Health to discuss critical considerations for navigating the changing access environment.
Navigating the upcoming changes to the EU HTA process
From partnering with industry as well as closely monitoring global pricing and reimbursement developments we believe that there is an increasingly acute need for a behavioral shift to achieve swift, quality, and long-lived access.
Regardless of the stage in the product lifecycle, the new reality of health technology assessment (HTA) processes in Europe means driving innovation through cross-functional operational excellence.
Coordinating operational excellence for fully enabled patient access: gain insights at our presentation on March 13
Our main-stage presentation on March 13 at 5:10pm will explore what the upcoming developments may mean for market access professionals, as well as share ideas to ensure preparation for the future, including:
- Regulatory to joint clinical assessment (JCA), HTA, and access
- Opportunities, barriers, and cross-functional collaboration
- Potential solutions
You will learn about the increasing need for cross-collaboration and consideration of the immediate and downstream stakeholders (colleagues, healthcare professionals, payers, patients) on the path to access. The need for pre-emptive and continuous engagement with regulatory agencies, healthcare professionals, patients, and payers will be examined, and you will gain recommendations on how to optimize final access and ensure appropriate value is generated for all.
We look forward to meeting you at World EPA Congress
Our expert team will be at the congress to discuss the critical considerations for navigating the changing access environment. Please contact us to arrange your meeting.
Partnering with you to make science accessible to every patient
Avalere Health has extensive experience in European HTA and JCA. Please contact us for a confidential conversation about your strategic policy, access, value, and evidence needs.
